US Patent Issued to Amgen on Aug. 18 for "Data-driven predictive modeling for cell line selection in biopharmaceutical production" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,730, issued on Aug. 18, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Data-driven predictive modeling for cell line selection in biopharmaceutical production" was invented by Kim H. Le (Thousand Oaks, Calif.), Yucen Xie (Cambridge, Mass.), Jennitte LeAnn Stevens (Thousand Oaks, Calif.) and Aaron Baskerville-Bridges (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for facilitating selection of cell lines to advance to a next stage of cell line screening includes receiving first attribute values for the candidate cell lines measured using an opto-electronic cell line generation and analysis system, and acquiring second ...